Can Invokana Do A Januvia In India?
This article was originally published in PharmAsia News
Executive Summary
Invokana has all the attributes to be a winner, to go by comments from Janssen India, but achieving success for the new diabetes brand will hinge on pricing, deft marketing and wide acceptance from medical practitioners. Ace marketing executive and chief of the subsidiary’s pharma business, Sanjiv Navangul, apparently also plans to deepen access to the drug in India through other new approaches.